Tech Company Financing Transactions
Abrexa Pharmaceuticals Funding Round
Abrexa Pharmaceuticals, based in San Diego, raised $500.8 thousand from private investors.
Transaction Overview
Company Name
Announced On
9/8/2011
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$500,793
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. $742.60 of total amount sold is purchase price of common stock issued; $500,000 is purchase price of convertible promissory notes issued; and $50 is purchase price of warrants to purchase capital stock. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12481 High Bluff Dr. 150
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Email Address
Not Recorded
Overview
Abrexa Pharmaceuticals is a stealth mode pharmaceutical development company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lynne Rollins
Browse more venture capital transactions:
Prev: 9/8/2011: Cardlytics venture capital transaction
Next: 9/8/2011: RingCentral venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs